Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehe

Updated on: June 16,2026

Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehe

Updated on:June 16,2026

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Updated on: July 18,2026

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Updated on:July 18,2026

GLP-1 use linked to lower breast cancer incidence in large cohort study

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who

Updated on: August 10,2026

GLP-1 use linked to lower breast cancer incidence in large cohort study

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who

Updated on:August 10,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on: July 28,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on:July 28,2026

Long-hidden 'junk DNA' regions may help explain cancer-linked genome instability

byUniversity of BarcelonaGenomic organization and regulatory biology of SST1/NBL2 macrosatellites. Credit:Trends in Genetics(2026). DOI: 10.1016/j.tig.2026.03.004Many repetitive regions of the genome

Updated on: August 20,2026

Long-hidden 'junk DNA' regions may help explain cancer-linked genome instability

byUniversity of BarcelonaGenomic organization and regulatory biology of SST1/NBL2 macrosatellites. Credit:Trends in Genetics(2026). DOI: 10.1016/j.tig.2026.03.004Many repetitive regions of the genome

Updated on:August 20,2026

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and

Updated on: August 02,2026

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and

Updated on:August 02,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on: August 06,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on:August 06,2026

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f

Updated on: August 11,2026

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f

Updated on:August 11,2026

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre

Updated on: August 08,2026

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre

Updated on:August 08,2026

Shrunken genomes may drive rapid cancer evolution and poor outcomes

by Thomas Deane,Trinity College DublinCredit: Pixabay/CC0 Public DomainResearchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor pa

Updated on: August 08,2026

Shrunken genomes may drive rapid cancer evolution and poor outcomes

by Thomas Deane,Trinity College DublinCredit: Pixabay/CC0 Public DomainResearchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor pa

Updated on:August 08,2026

Smartphone app helps those with advanced cancer maintain quality of life

by Dennis ThompsonA smartphone app can help individuals with advanced cancer deal with symptoms and maintain their quality of life, according to new research.TheSUPPORT+ appasks them each week to comp

Updated on: August 15,2026

Smartphone app helps those with advanced cancer maintain quality of life

by Dennis ThompsonA smartphone app can help individuals with advanced cancer deal with symptoms and maintain their quality of life, according to new research.TheSUPPORT+ appasks them each week to comp

Updated on:August 15,2026

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Updated on: July 27,2026

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Updated on:July 27,2026